REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion

The objective of this observational non-randomized multicenter study is to compile real-world clinical characteristics and outcomes data for patients treated with LAA (left atrial appendage) closure systems in a daily clinical setting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Embolism and Thrombosis Heart Diseases Hemorrhage Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Stroke Thrombosis Vascular Diseases

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who are eligible for a LAA occlusion device and treated with a commercially available device according to international and local guidelines and per physician discretion.

Exclusion criteria

None

Treatment and study plan

Percutaneous Left Atrial Appendage Occlusion

Device

Percutaneous left atrial appendage occlusion in routine care for patients with atrial fibrillation

Primary outcomes

Major adverse cardiovascular events

Time frame: From date of inclusion until the date of first documented event, whichever came first, assessed up to 60 months

Death, Ischemic stroke, Transient ischemic attack, Major hemorrhage, Thrombus on device

Sponsors and collaborators

Lead sponsor

University Hospital, Tours

Other

Registry information

Official study title

REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion for Patients With Atrial Fibrillation in France

Acronym: RELEXAO

Important dates

Study start: 2012
Primary completion: 2018
Study completion: 2018
First posted: Sep 12, 2017
Registry last updated: May 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting